Literature DB >> 7529982

Mitochondrial DNA 8993 (NARP) mutation presenting with a heterogeneous phenotype including 'cerebral palsy'.

A Fryer1, R Appleton, M G Sweeney, L Rosenbloom, A E Harding.   

Abstract

The mitochondrial DNA (mtDNA) mutation 8993 is an important cause of Leigh's encephalopathy. A family is reported where other affected members have presented with non-specific delayed development or cerebral palsy. The diagnosis should be considered not only in children with Leigh's encephalopathy, but also in those with mild neurological dysfunction (including cerebral palsy) if there is a pigmentary retinopathy or a family history of neurological or ophthalmological disease. There was some correlation in this family between the disease severity and the proportion of mutant mtDNA in the blood. This mutation appears to segregate to high levels of mutant mtDNA rapidly within pedigrees and the mother of a severely affected child has a high risk of having further children with a high proportion of mutant mtDNA and a severe phenotype.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529982      PMCID: PMC1030055          DOI: 10.1136/adc.71.5.419

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  Mitochondrial DNA mutation and Leigh's syndrome.

Authors:  R Sakuta; Y Goto; S Horai; T Ogino; H Yoshinaga; S Ohtahara; I Nonaka
Journal:  Ann Neurol       Date:  1992-10       Impact factor: 10.422

2.  Subacute necrotizing encephalopathy: oxidative phosphorylation defects and the ATPase 6 point mutation.

Authors:  J M Shoffner; P M Fernhoff; N S Krawiecki; D B Caplan; P J Holt; D A Koontz; Y Takei; N J Newman; R G Ortiz; M Polak
Journal:  Neurology       Date:  1992-11       Impact factor: 9.910

3.  Prenatal diagnosis of mitochondrial DNA8993 T----G disease.

Authors:  A E Harding; I J Holt; M G Sweeney; M Brockington; M B Davis
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

4.  A new mitochondrial disease associated with mitochondrial DNA heteroplasmy.

Authors:  I J Holt; A E Harding; R K Petty; J A Morgan-Hughes
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

5.  A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome.

Authors:  D D de Vries; B G van Engelen; F J Gabreëls; W Ruitenbeek; B A van Oost
Journal:  Ann Neurol       Date:  1993-09       Impact factor: 10.422

6.  Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high.

Authors:  Y Tatuch; J Christodoulou; A Feigenbaum; J T Clarke; J Wherret; C Smith; N Rudd; R Petrova-Benedict; B H Robinson
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

7.  Maternally inherited Leigh syndrome.

Authors:  E Ciafaloni; F M Santorelli; S Shanske; T Deonna; E Roulet; C Janzer; G Pescia; S DiMauro
Journal:  J Pediatr       Date:  1993-03       Impact factor: 4.406

8.  The 8993 mtDNA mutation: heteroplasmy and clinical presentation in three families.

Authors:  Y Tatuch; R A Pagon; B Vlcek; R Roberts; M Korson; B H Robinson
Journal:  Eur J Hum Genet       Date:  1994       Impact factor: 4.246

9.  The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome.

Authors:  F M Santorelli; S Shanske; A Macaya; D C DeVivo; S DiMauro
Journal:  Ann Neurol       Date:  1993-12       Impact factor: 10.422

10.  Heteroplasmy in Leber's hereditary optic neuropathy.

Authors:  K H Smith; D R Johns; K L Heher; N R Miller
Journal:  Arch Ophthalmol       Date:  1993-11
  10 in total
  12 in total

1.  Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993.

Authors:  S L White; V R Collins; R Wolfe; M A Cleary; S Shanske; S DiMauro; H H Dahl; D R Thorburn
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue- or age-related variation.

Authors:  S L White; S Shanske; J J McGill; H Mountain; M T Geraghty; S DiMauro; H H Dahl; D R Thorburn
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

Review 3.  Cerebral palsy: not always what it seems.

Authors:  R Gupta; R E Appleton
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

Review 4.  The relationship between pluripotency and mitochondrial DNA proliferation during early embryo development and embryonic stem cell differentiation.

Authors:  J M Facucho-Oliveira; J C St John
Journal:  Stem Cell Rev Rep       Date:  2009-04-03       Impact factor: 5.739

5.  Cone and rod dysfunction in the NARP syndrome.

Authors:  I Chowers; T Lerman-Sagie; O N Elpeleg; A Shaag; S Merin
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

Review 6.  Dysregulation of multiple signaling pathways: A possible cause of cerebral palsy.

Authors:  Jyoti Upadhyay; Mohd Nazam Ansari; Abdul Samad; Ashutosh Sayana
Journal:  Exp Biol Med (Maywood)       Date:  2022-03-07

Review 7.  Diagnosis of inherited metabolic disorders affecting the nervous system.

Authors:  P D Swanson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

8.  Tall stature and progressive overweight in mitochondrial encephalopathy.

Authors:  E Morava; F A Hol; A Janssen; J Smeitink
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 9.  Mitochondrial dysfunction in neurodegenerative diseases.

Authors:  Anthony H V Schapira
Journal:  Neurochem Res       Date:  2008-11-08       Impact factor: 3.996

10.  NARP Syndrome: A 20-Year Follow-Up.

Authors:  Mark J Rawle; A J Larner
Journal:  Case Rep Neurol       Date:  2013-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.